IDC-G103 (Immune Design)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIDC-G103 (Immune Design)
Drug Alias NameHerpes symplex virus 2 vaccine (Immune Design)HSV therapeutic vaccine (Immune Design)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Design
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Design
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A